Literature DB >> 8782302

Nodular lymphoid hyperplasia of the terminal ileum: report of a case and the findings of an immunological analysis.

H Yamaue1, H Tanimura, K Ishimoto, Y Morikawa, K Kakudo.   

Abstract

The immunological and immunohistochemical characteristics of a patient with nodular lymphoid hyperplasia (NLH) of the terminal ileum were investigated pre- and post-operatively. The patient presented with diarrhea, lower abdominal pain, and weight loss, and an abdominal X-ray following barium enema revealed multiple small nodules in the terminal ileum which were subsequently confirmed to be NLH by histological examination. Preoperatively, although the serum immunoglobulin levels were normal, the T-cell responses in the peripheral blood, including the phytohemagglutinin (PHA)-blastogenesis and the T4/T8 ratio, were impaired. However, following an ileocecal resection, the PHA-blastogenesis became augmented and the T4/T8 ratio recovered to within the normal range. The immunohistochemical findings revealed a more marked accumulation of T cells in the interstitium around the hyperplastic follicles than in the interstitium of the normal intestine.

Entities:  

Mesh:

Year:  1996        PMID: 8782302     DOI: 10.1007/bf00311931

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  18 in total

1.  Clinical and immunologic observations in a patient with late onset immunodeficiency.

Authors:  G N Tytgat; K Huibregtse; P T Schellekens; T H Feltkamp-Vroom
Journal:  Gastroenterology       Date:  1979-06       Impact factor: 22.682

2.  Bleeding lymphoid hyperplasia of the small bowel in an adolescent diagnosed by intraoperative endoscopy.

Authors:  E Essenfeld-Sekler; C Paez; A Toledano; E Congedo; M Guelrud; E Roa
Journal:  Gastrointest Endosc       Date:  1979-02       Impact factor: 9.427

3.  Florid reactive lymphoid hyperplasia of the terminal ileum in adults: a condition bearing a close resemblance to low-grade malignant lymphoma.

Authors:  A Rubin; P G Isaacson
Journal:  Histopathology       Date:  1990-07       Impact factor: 5.087

4.  Intestinal nodular lymphoid hyperplasia in patients with common variable immunodeficiency: local accumulation of B and CD8(+) lymphocytes.

Authors:  P Van den Brande; K Geboes; G Vantrappen; A Van den Eeckhout; S Vertessen; E A Stevens; J L Ceuppens
Journal:  J Clin Immunol       Date:  1988-07       Impact factor: 8.317

5.  B cell numbers and responses in patients with common variable immunodeficiency and nodular lymphoid hyperplasia of the bowel.

Authors:  F M Caballero; W R Brown; P F Kohler; A R Hayward
Journal:  J Clin Lab Immunol       Date:  1984-02

6.  Lymphoid hyperplasia of the gastrointestinal tract. A study of 26 cases and review of the literature.

Authors:  M Ranchod; K J Lewin; R F Dorfman
Journal:  Am J Surg Pathol       Date:  1978-12       Impact factor: 6.394

7.  Common variable immunodeficiency syndrome and nodular lymphoid hyperplasia in the small intestine.

Authors:  C Bästlein; R Burlefinger; E Holzberg; C Voeth; M Garbrecht; R Ottenjann
Journal:  Endoscopy       Date:  1988-09       Impact factor: 10.093

8.  Lymphoid hyperplasia of small bowel in an adult female.

Authors:  A P Crawford
Journal:  Med J Aust       Date:  1979-06-02       Impact factor: 7.738

9.  Symptomatic benign lymphoid hyperplasia of the terminal ileum in an adult.

Authors:  D T Stueland; N C Binkley; G E Magnin
Journal:  Am J Gastroenterol       Date:  1980-12       Impact factor: 10.864

Review 10.  High-grade non-Hodgkin's lymphoma complicating polypoid nodular lymphoid hyperplasia and multiple lymphomatous polyposis of the intestine.

Authors:  M Harris; R W Blewitt; V J Davies; W P Steward
Journal:  Histopathology       Date:  1989-10       Impact factor: 5.087

View more
  1 in total

1.  Contrast enhanced magnetic resonance imaging of the terminal ileum in children with Crohn's disease.

Authors:  A Laghi; O Borrelli; P Paolantonio; L Dito; M Buena de Mesquita; P Falconieri; R Passariello; S Cucchiara
Journal:  Gut       Date:  2003-03       Impact factor: 23.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.